Germaine Fuh

9.8k total citations · 2 hit papers
62 papers, 7.5k citations indexed

About

Germaine Fuh is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Germaine Fuh has authored 62 papers receiving a total of 7.5k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 22 papers in Radiology, Nuclear Medicine and Imaging and 17 papers in Oncology. Recurrent topics in Germaine Fuh's work include Angiogenesis and VEGF in Cancer (22 papers), Monoclonal and Polyclonal Antibodies Research (21 papers) and Glycosylation and Glycoproteins Research (16 papers). Germaine Fuh is often cited by papers focused on Angiogenesis and VEGF in Cancer (22 papers), Monoclonal and Polyclonal Antibodies Research (21 papers) and Glycosylation and Glycoproteins Research (16 papers). Germaine Fuh collaborates with scholars based in United States, France and United Kingdom. Germaine Fuh's co-authors include James A. Wells, Abraham M. de Vos, Brian C. Cunningham, Chingwei V. Lee, Hans W. Christinger, Christian Wiesmann, Napoleone Ferrara, Charles Eigenbrot, Sachdev S. Sidhu and Hans‐Peter Gerber and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Germaine Fuh

62 papers receiving 7.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells

2007 673 citations Farbod Shojaei, Xiumin Wu et al. Nature Biotechnology profile →
Rational Design of Potent Antagonists to the Human Growth Hormone Receptor

1992 527 citations Germaine Fuh, Brian C. Cunningham et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Germaine Fuh United States	45	5.0k	2.0k	1.9k	1.3k	1.2k	62	7.5k
Andrius Kazlauskas United States	60	9.8k 2.0×	1.9k 1.0×	2.4k 1.2×	2.3k 1.8×	1.3k 1.1×	188	15.1k
Donald P. Bottaro United States	54	8.0k 1.6×	538 0.3×	2.6k 1.3×	1.0k 0.8×	1.4k 1.2×	165	12.5k
Ivan Gout United Kingdom	52	9.7k 2.0×	978 0.5×	1.7k 0.9×	2.3k 1.8×	592 0.5×	157	12.8k
Jaime A. Escobedo United States	26	5.4k 1.1×	528 0.3×	1.2k 0.6×	771 0.6×	814 0.7×	38	7.0k
G Carpenter United States	35	7.1k 1.4×	1.9k 1.0×	3.0k 1.5×	917 0.7×	731 0.6×	58	10.8k
Graham Carpenter United States	60	7.5k 1.5×	2.2k 1.1×	3.8k 2.0×	1.2k 0.9×	871 0.7×	120	11.7k
Masabumi Shibuya Japan	41	4.6k 0.9×	306 0.2×	1.7k 0.9×	990 0.7×	1.2k 1.0×	77	6.6k
Marc Vooijs Netherlands	45	4.9k 1.0×	547 0.3×	2.0k 1.1×	633 0.5×	1.4k 1.2×	108	8.0k
David F. Stern United States	64	7.6k 1.5×	2.9k 1.4×	5.8k 3.0×	1.0k 0.8×	1.5k 1.3×	140	12.6k
Burt G. Feuerstein United States	46	4.8k 1.0×	968 0.5×	1.3k 0.7×	444 0.3×	2.2k 1.9×	119	8.4k

Countries citing papers authored by Germaine Fuh

Since Specialization

Citations

This map shows the geographic impact of Germaine Fuh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Germaine Fuh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Germaine Fuh more than expected).

Fields of papers citing papers by Germaine Fuh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Germaine Fuh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Germaine Fuh. The network helps show where Germaine Fuh may publish in the future.

Co-authorship network of co-authors of Germaine Fuh

This figure shows the co-authorship network connecting the top 25 collaborators of Germaine Fuh. A scholar is included among the top collaborators of Germaine Fuh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Germaine Fuh. Germaine Fuh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Benjamin, Joel S., Abigail Jarret, Shashank Bharill, et al.. (2024). Abstract 2375: 23ME-01473, a novel anti-ULBP6/2/5 monoclonal antibody, reinvigorates anti-tumor NK cell function through NKG2D and FcγRIIIa activation. Cancer Research. 84(6_Supplement). 2375–2375. 1 indexed citations

Ultsch, Mark, Bing Li, Till Maurer, et al.. (2016). Structure of Crenezumab Complex with Aβ Shows Loss of β-Hairpin. Scientific Reports. 6(1). 39374–39374. 90 indexed citations

Zhou, Huanjiao Jenny, Lingfeng Qin, Haifeng Zhang, et al.. (2016). Endothelial exocytosis of angiopoietin-2 resulting from CCM3 deficiency contributes to cerebral cavernous malformation. Nature Medicine. 22(9). 1033–1042. 88 indexed citations

Lee, Chingwei V., Patrick Koenig, & Germaine Fuh. (2014). A Two-in-One antibody engineered from a humanized interleukin 4 antibody through mutation in heavy chain complementarity-determining regions. mAbs. 6(3). 622–627. 19 indexed citations

Eigenbrot, Charles & Germaine Fuh. (2013). Two-in-One antibodies with dual action Fabs. Current Opinion in Chemical Biology. 17(3). 400–405. 31 indexed citations

Boström, Jenny, Lauric Haber, Patrick Koenig, Robert F. Kelley, & Germaine Fuh. (2011). High Affinity Antigen Recognition of the Dual Specific Variants of Herceptin Is Entropy-Driven in Spite of Structural Plasticity. PLoS ONE. 6(4). e17887–e17887. 66 indexed citations

Bagri, Anil, Leanne Berry, Bert Gunter, et al.. (2010). Effects of Anti-VEGF Treatment Duration on Tumor Growth, Tumor Regrowth, and Treatment Efficacy. Clinical Cancer Research. 16(15). 3887–3900. 110 indexed citations

Boström, Jenny, Shang‐Fan Yu, David Kan, et al.. (2009). Variants of the Antibody Herceptin That Interact with HER2 and VEGF at the Antigen Binding Site. Science. 323(5921). 1610–1614. 263 indexed citations

Campa, Claudio, Ian Kasman, Weilan Ye, et al.. (2008). Effects of an Anti–VEGF-A Monoclonal Antibody on Laser-Induced Choroidal Neovascularization in Mice: Optimizing Methods to Quantify Vascular Changes. Investigative Ophthalmology & Visual Science. 49(3). 1178–1178. 60 indexed citations

10.

Boström, Jenny, Chingwei V. Lee, Lauric Haber, & Germaine Fuh. (2008). Improving Antibody Binding Affinity and Specificity for Therapeutic Development. Methods in molecular biology. 525. 353–376. 42 indexed citations

11.

Berry, Leanne, Kai Barck, Mary Ann T. Go, et al.. (2008). Quantification of viable tumor microvascular characteristics by multispectral analysis. Magnetic Resonance in Medicine. 60(1). 64–72. 40 indexed citations

12.

Shojaei, Farbod, Xiumin Wu, Ajay K. Malik, et al.. (2007). Tumor refractoriness to anti-VEGF treatment mediated by CD11b+Gr1+ myeloid cells. Molecular Cancer Therapeutics. 6. 1 indexed citations

13.

Shojaei, Farbod, Xiumin Wu, Ajay K. Malik, et al.. (2007). Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells. Nature Biotechnology. 25(8). 911–920. 673 indexed citations breakdown →

14.

Lee, Chingwei V., S.G. Hymowitz, Heidi J.A. Wallweber, et al.. (2006). Synthetic anti-BR3 antibodies that mimic BAFF binding and target both human and murine B cells. Blood. 108(9). 3103–3111. 48 indexed citations

15.

Lee, Chingwei V., Sachdev S. Sidhu, & Germaine Fuh. (2003). Bivalent antibody phage display mimics natural immunoglobulin. Journal of Immunological Methods. 284(1-2). 119–132. 69 indexed citations

16.

Fuh, Germaine, M. Teresa Pisabarro, Ying Li, et al.. (2000). Analysis of PDZ Domain-Ligand Interactions Using Carboxyl-terminal Phage Display. Journal of Biological Chemistry. 275(28). 21486–21491. 149 indexed citations

17.

Fuh, Germaine. (2000). The interaction of Neuropilin-1 with Vascular Endothelial Growth Factor and its receptor Flt-1. Journal of Biological Chemistry. 275(35). 26690–5. 243 indexed citations

18.

Chen, Yvonne, Christian Wiesmann, Germaine Fuh, et al.. (1999). Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured fab in complex with antigen 1 1Edited by I. A. Wilson. Journal of Molecular Biology. 293(4). 865–881. 370 indexed citations

19.

Wiesmann, Christian, Germaine Fuh, Hans W. Christinger, et al.. (1997). Crystal Structure at 1.7 Å Resolution of VEGF in Complex with Domain 2 of the Flt-1 Receptor. Cell. 91(5). 695–704. 402 indexed citations

20.

Wells, James A., Brian C. Cunningham, Germaine Fuh, et al.. (1993). The Molecular Basis for Growth Hormone–Receptor Interactions. PubMed. 48. 253–275. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact